Importance of β2AR elevation for re-endothelialization capacity mediated by late endothelial progenitor cells in hypertensive patients

Dysfunction of late endothelial progenitor cells (EPCs) has been suggested to be associated with hypertension. beta(2)-Adrenergic receptor (beta(2)AR) is a novel and key target for EPC homing. Here, we proposed that attenuated beta(2)AR signaling contributes to EPCs dysfunction, whereas enhanced beta(2)AR signaling restores EPCs' functions in hypertension. EPCs derived from hypertensive patients exhibited reduced cell number, impaired in vitro migratory and adhesion abilities, and impaired re-endothelialization after transplantation in nude mice with carotid artery injury. beta(2)AR expression of EPCs from hypertensive patients was markedly downregulated, whereas the phosphorylation of the p38 mitogen-activated protein kinase (p38-MAPK) was elevated. The cleaved caspase-3 levels were elevated in EPCs. The overexpression of beta(2)AR in EPCs from hypertensive patients inhibited p38MAPK signaling, whereas it enhanced in vitro EPC proliferation, migration, and adhesion and in vivo re-endothelialization. The beta(2)AR-mediated effects were attenuated by treating the EPCs with a neutralizing monoclonal antibody against beta(2)AR, which could be partially antagonized by the p38-MAPK inhibitor SB203580. Moreover, shear stress stimulation, a classic nonpharmacological intervention, increased the phosphorylation levels of beta(2)AR and enhanced the in vitro and in vivo functions of EPCs from hypertensive patients. Collectively, the current investigation demonstrated that impaired beta(2)AR/p38-MAPK/caspase-3 signaling at least partially reduced the re-endothelialization capacity of EPCs from hypertensive patients. Restoration of beta(2)AR expression and shear stress treatment could improve their endothelial repair capacity by regulating the p38-MAPK/caspase-3 signaling pathway. The clinical significance of NAR in endothelium repair still requires further investigation. NEW & NOTEWORTHY Impaired beta(2)-adrenergic receptor (beta(2)AR) expression with an elevation of p38-MAPK/caspase-3 signaling at least partially contributes to the decline of re-endothelialization capacity of late endothelial progenitor cells (EPCs) from hypertensive patients. beta(2)AR gene transfer and shear stress treatment improve the late EPC-mediated enhancement of the re-endothelialization capacity in hypertensive patients through activating beta(2)AR/p38-MAPK/caspase-3 signaling. The present study is the first to reveal the potential molecular mechanism of the impaired endothelium-reparative capacity of late EPCs in hypertension after vascular injury and strongly suggests that beta(2)AR is a novel and crucial therapeutic target for increasing EPC-mediated re-endothelialization capacity in hypertension.

Automated summary

Impaired beta(2)AR expression with elevated p38-MAPK/caspase-3 signaling contributes to the dysfunction of late EPCs in hypertensive patients. Restoring beta(2)AR expression and shear stress treatment can enhance the re-endothelialization capacity of EPCs by regulating the p38-MAPK/caspase-3 signaling pathway. This study highlights beta(2)AR as a potential therapeutic target for improving EPC-mediated endothelial repair in hypertension.